Ind Swift Profile
Key Indicators
- Authorised Capital ₹ 40.00 Cr
- Paid Up Capital ₹ 25.03 Cr
- Company Age 38 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5,494.73 Cr
- Satisfied Charges ₹ 845.60 Cr
- Revenue Growth 0.37%
- Profit Growth 230.05%
- Ebitda -7.31%
- Net Worth 2.17%
- Total Assets 2.76%
About Ind Swift
Ind Swift Limited (ISL) is a leading Public Limited Indian Non-Government Company incorporated in India on 06 June 1986 and has a history of 38 years and eight months. Its registered office is in Chandigarh, Chandigarh, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 524652 and on the National Stock Exchange(NSE) under INDSWFTLTD.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 40.00 Cr and a paid-up capital of Rs 25.03 Cr.
The company currently has active open charges totaling ₹5,494.73 Cr. The company has closed loans amounting to ₹845.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Ind Swift Limited India are Arun Seth as CFO and Ginny Uppal as Company Secretary. Gopal Munjal, Sanjeev Mehta, Vikrant Mehta, and Nine other members serve as directors at the Company.
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L24230CH1986PLC006897
- Company No.
006897
- Stock Symbol
BSE : 524652 NSE : INDSWFTLTD
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
06 Jun 1986
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Chandigarh
Industry
What products or services does Ind Swift Limited offer?
Ind Swift Limited offers a wide range of products and services, including Contract Employment & Staffing Firms, Manpower Service, Science Models, Biological Models, Dentist Tools, Equipment & Supplies, Dentures, Human Anatomical Models, Pharmaceutical Syrup, Dry Syrups, Industrial Steel.
Who are the key members and board of directors at Ind Swift?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gopal Munjal  | Managing Director | 11-Dec-1986 | Current |
| Arun Seth | CFO | 13-Feb-2015 | Current |
| Ginny Uppal | Company Secretary | 30-May-2022 | Current |
Board Members (11)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjeev Mehta | Whole-Time Director | 30-Nov-2006 | Current |
| Vikrant Mehta | Whole-Time Director | 30-Sep-1993 | Current |
| Himanshu Jain | Director | 31-Jul-2003 | Current |
| Navrattan Munjal | Director | 11-Dec-2006 | Current |
| Subodh Gupta | Additional Director | 25-Apr-2024 | Current |
| Rishav Mehta | Additional Director | 23-Mar-2010 | Current |
Financial Performance of Ind Swift.
Ind Swift Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.37% increase. The company also saw a substantial improvement in profitability, with a 230.05% increase in profit. The company's net worth moved up by a moderate rise of 2.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ind Swift?
In 2022, Ind Swift had a promoter holding of 55.58% and a public holding of 44.42%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Immacule Lifesciences Private LimitedGinny Uppal is a mutual person
Acme Generics Private LimitedGinny Uppal is a mutual person
- Acme Formulation Private Limited
Ginny Uppal is a mutual person
Ind Swift Laboratories LimitedHimanshu Jain, Navrattan Munjal and 1 more are mutual person
Indis Healthcare LlpHimanshu Jain is a mutual person
- Mjm Remedies Private Limited
Himanshu Jain and Navrattan Munjal are mutual person
Charges (Loans)
₹5,494.73 Cr
₹845.60 Cr
Charges Breakdown by Lending Institutions
- Others : 5362.79 Cr
- Consortium Pnb Uti Sbi State Bank Of Indore : 83.00 Cr
- Export-Import Bank Of India : 30.00 Cr
- Axis Bank Limited : 13.30 Cr
- Hdfc Bank Ltd.. : 3.00 Cr
- Others : 2.64 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Aug 2023 | Others | ₹5.00 M | Open |
| 23 Oct 2020 | Axis Bank Limited | ₹1.10 Cr | Open |
| 07 Oct 2020 | Axis Bank Limited | ₹1.50 Cr | Open |
| 30 Sep 2019 | Axis Bank Limited | ₹10.70 Cr | Open |
| 28 Mar 2013 | Others | ₹1,002.87 Cr | Open |
How Many Employees Work at Ind Swift?
Ind Swift has a workforce of 1205 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ind Swift, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ind Swift's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
